Neogen Corporation Expects Genomics Sale Regulatory Review to Conclude in early 2027

Neogen said its definitive agreement to sell its global Genomics business to Zoetis, entered into on March 2, 2026, remains subject to customary closing conditions and regulatory approvals. The parties continue to cooperate; the article provides no transaction value or expected closing date.